LAYLA ABUSHAMAT to Obesity
This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Obesity.
Connection Strength
0.690
-
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity? Curr Cardiol Rep. 2024 Sep; 26(9):1011-1019.
Score: 0.385
-
Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e2939-e2945.
Score: 0.104
-
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. Clin Gastroenterol Hepatol. 2024 Aug; 22(8):1565-1574.
Score: 0.093
-
Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes. J Am Heart Assoc. 2023 05 16; 12(10):e029944.
Score: 0.089
-
Obesity Management in Cardiometabolic Disease: State of the Art. Curr Atheroscler Rep. 2021 08 04; 23(10):59.
Score: 0.020